Applied Cognitive Diagnostics Competitors

The University of Southern California is a leading private research university located in Los Angeles, the capital of the Pacific Rim. This is the official LinkedIn presence for the University of Southern California. This account is managed and mediated by the staff of USC University Communications. Content (including posts from 3rd parties) that include videos, photographs, opinions and links to content outside of this channel do not necessarily represent the University of Southern California’s academic goals or opinions. Community guidelines: Alumni and students are welcome to post professional updates and news. Posts containing solicitations, product placements, derogatory or inflammatory comments are prohibited and will be removed. Off-topic comments will also be removed. Posts are not regularly monitored. Please note: for questions regarding degrees offered and admissions policies please call (213) 740-2311.

Eisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology. In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), with working on various activities together with global partners.

Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world. NeuroStar is the #1 TMS choice of doctors, with over 4.3 million treatments performed to date. It is an advanced treatment for depression. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target depression where it starts — the brain. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world. If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207. Please visit NeuroStar.com/Safety for full safety and prescribing information.